Aerospace & Defense · Founded 1985 · www.sikaglobal.com · BSE 523606 · NSE SIKA INTER. · ISIN INE438E01032
No Notes Added Yet
Business
Sika Interplant Systems Ltd. is an Indian engineering and manufacturing company primarily engaged in providing precision engineering solutions, manufacturing of critical components, systems integration, and Maintenance, Repair, and Overhaul (MRO) services. While it caters to various sectors including automotive and industrial, its core focus is on the Defence and Aerospace industries. The company manufactures a range of products including hydraulic and pneumatic systems, electromechanical assemblies, test equipment, and precision machined components. It makes money by selling these specialized products and services to government entities, Defence Public Sector Undertakings (DPSUs) like Hindustan Aeronautics Limited (HAL), Bharat Electronics Limited (BEL), Defence Research and Development Organisation (DRDO), and Indian shipyards.
Revenue Mix
Sika Interplant Systems Ltd. broadly operates across engineering services, manufacturing, and MRO. While specific revenue percentages for each segment are not typically disclosed, the company's primary focus and revenue generation come from its activities in:
Defence & Aerospace: This segment likely constitutes the majority, involving the supply of components, sub-systems, ground support equipment, and MRO services for aircraft, naval vessels, and land systems.
Automotive & Industrial: Production of specialized components and systems for the automotive and general industrial sectors.
The company's offerings span hydraulics, pneumatics, electromechanics, and test solutions, which are integrated into these key end-use segments.
Industry
The Indian Defence industry is highly strategic, largely driven by government procurement, with a strong push towards indigenization ("Make in India," "Atmanirbhar Bharat"). The industry is characterized by long development and procurement cycles, high technology requirements, and stringent quality standards. Sika Interplant Systems operates as a Tier 1/Tier 2 supplier and MRO partner to major DPSUs and the Ministry of Defence. It is positioned as a niche player offering specialized engineering and manufacturing capabilities, complementing the larger DPSUs and some private conglomerates. While it doesn't compete directly with large system integrators like L&T or Bharat Forge on all fronts, it holds expertise in specific component and sub-system areas.
MOAT
Sika Interplant Systems' competitive advantages include:
Specialized Expertise: Deep domain knowledge and engineering capabilities in precision manufacturing, hydraulics, pneumatics, and electromechanical systems, particularly relevant for defence and aerospace applications.
Long-Standing Relationships: Established track record and relationships with key Indian defence entities (HAL, BEL, DRDO, Indian Navy, Indian Air Force), which are difficult for new entrants to build.
Certifications & Approvals: Possession of necessary defence and aerospace certifications and accreditations, signifying compliance with stringent quality and manufacturing standards.
Customization & Integration: Ability to offer customized solutions and complex system integration services, providing value beyond mere component supply.
MRO Capabilities: Provision of critical MRO services, creating recurring revenue streams and strengthening client relationships over the long lifecycle of defence assets.
Growth Drivers
Increased Defence Budget & Modernization: Continued allocation of funds by the Indian government for modernizing its armed forces, leading to higher procurement and MRO spending.
"Make in India" & "Atmanirbhar Bharat" Initiatives: Government thrust on indigenization and reducing import dependency for defence equipment, creating significant opportunities for domestic manufacturers.
Increased Private Sector Participation: Growing policy support and avenues for private players to contribute to defence manufacturing and R&D.
Export Potential: Potential for exporting specialized components and systems to friendly foreign nations, aligning with India's defence export policy.
Technology Upgrades: Need for continuous upgrades and maintenance of existing defence platforms, driving demand for MRO and new sub-systems.
Risks
Dependence on Government Orders: A significant portion of revenue is tied to government contracts and DPSU orders, making the company susceptible to defence budget fluctuations, policy changes, and delays in procurement cycles.
Long Sales & Project Cycles: The defence sector is characterized by prolonged bidding, approval, and execution phases, impacting revenue recognition and cash flow.
Intense Competition: Competition from other private Indian defence manufacturers, global OEMs operating in India, and existing DPSUs.
Technological Obsolescence: Risk of technology becoming outdated, requiring continuous R&D investment to remain competitive.
Regulatory & Compliance Risks: Operating in a highly regulated sector with strict import/export controls and compliance requirements.
Raw Material & Component Sourcing: Potential dependency on imported raw materials or specialized components, exposing the company to supply chain disruptions and currency fluctuations.
Management & Ownership
Sika Interplant Systems Ltd. is promoted by Mr. Rakesh Sachdev and his family, who have a long history in the engineering and manufacturing sector. Mr. Rakesh Sachdev serves as the Chairman & Managing Director, bringing substantial experience in precision engineering and defence solutions. The company's ownership structure typically features a significant promoter holding, indicating family control and long-term commitment. Management quality is generally seen through their ability to secure and execute complex defence contracts over time.
Outlook
Sika Interplant Systems Ltd. operates in a sector with significant tailwinds from the Indian government's focus on defence indigenization and modernization. The "Make in India" initiative presents a substantial long-term growth opportunity, allowing the company to leverage its specialized engineering and manufacturing capabilities to expand its offerings and client base within the domestic market. However, the company faces inherent challenges of the defence sector, including lengthy procurement cycles, dependency on government spending, and intense competition. Its ability to continuously innovate, manage complex projects, and maintain strong relationships with key defence customers will be critical for sustained growth. While the sector's strategic importance provides a robust foundation, the cyclical nature of defence spending and the need for ongoing technological investment necessitate a cautious but optimistic outlook.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 37 | 30 | 33 | 38 | 46 | 68 | 52 | 50 | 41 | 43 |
| Other Income | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 0 | 3 |
| Total Income | 38 | 32 | 35 | 39 | 48 | 70 | 53 | 52 | 42 | 45 |
| Total Expenditure | 31 | 24 | 26 | 30 | 38 | 56 | 41 | 39 | 31 | 35 |
| Operating Profit | 8 | 7 | 8 | 9 | 10 | 14 | 12 | 13 | 11 | 11 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 8 | 7 | 8 | 9 | 10 | 14 | 12 | 13 | 10 | 10 |
| Provision for Tax | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 2 |
| Profit After Tax | 6 | 5 | 6 | 7 | 8 | 10 | 9 | 9 | 8 | 8 |
| Adjustments | 0 | 0 | -0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 6 | 5 | 6 | 7 | 8 | 10 | 9 | 9 | 8 | 8 |
| Adjusted Earnings Per Share | 2.9 | 2.5 | 2.9 | 3.4 | 3.7 | 4.9 | 4.2 | 4.5 | 3.7 | 4 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 42 | 34 | 22 | 46 | 63 | 80 | 98 | 60 | 106 | 148 | 211 | 186 |
| Other Income | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 5 | 6 | 5 | 5 |
| Total Income | 42 | 36 | 23 | 47 | 64 | 82 | 102 | 63 | 111 | 154 | 216 | 192 |
| Total Expenditure | 39 | 32 | 20 | 39 | 54 | 64 | 78 | 50 | 86 | 118 | 166 | 146 |
| Operating Profit | 4 | 4 | 3 | 7 | 10 | 18 | 24 | 13 | 26 | 35 | 51 | 47 |
| Interest | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | -0 | 0 | 0 |
| Profit Before Tax | 3 | 3 | 2 | 6 | 9 | 16 | 22 | 12 | 25 | 33 | 49 | 45 |
| Provision for Tax | 1 | 1 | 0 | 2 | 2 | 4 | 6 | 3 | 6 | 8 | 12 | 11 |
| Profit After Tax | 2 | 2 | 1 | 4 | 7 | 12 | 17 | 9 | 19 | 25 | 36 | 34 |
| Adjustments | 0 | -0 | 0 | 0 | -0 | 0 | -1 | 0 | 0 | -0 | 0 | 0 |
| Profit After Adjustments | 2 | 2 | 1 | 4 | 7 | 12 | 15 | 9 | 19 | 25 | 37 | 34 |
| Adjusted Earnings Per Share | 0.8 | 0.9 | 0.7 | 2 | 3.3 | 5.6 | 7.3 | 4.3 | 9.2 | 11.7 | 17.3 | 16.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 43% | 52% | 21% | 18% |
| Operating Profit CAGR | 46% | 58% | 23% | 29% |
| PAT CAGR | 44% | 59% | 25% | 34% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -24% | 58% | 47% | 38% |
| ROE Average | 26% | 23% | 21% | 14% |
| ROCE Average | 36% | 31% | 28% | 20% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 40 | 42 | 43 | 46 | 53 | 64 | 78 | 85 | 103 | 124 | 156 |
| Minority's Interest | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1 | 1 | 1 | 2 | 1 | 2 | 3 | 3 | 3 | 3 | 4 |
| Total Current Liabilities | 14 | 4 | 4 | 14 | 15 | 14 | 16 | 15 | 15 | 24 | 14 |
| Total Liabilities | 55 | 50 | 50 | 64 | 70 | 81 | 98 | 103 | 122 | 152 | 174 |
| Fixed Assets | 35 | 37 | 37 | 37 | 37 | 37 | 36 | 36 | 43 | 45 | 44 |
| Other Non-Current Assets | 3 | 6 | 6 | 9 | 19 | 2 | 10 | 20 | 34 | 38 | 81 |
| Total Current Assets | 18 | 7 | 8 | 18 | 14 | 42 | 53 | 48 | 45 | 69 | 49 |
| Total Assets | 55 | 50 | 50 | 64 | 70 | 81 | 98 | 103 | 122 | 152 | 174 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 2 | -0 | 0 | -1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Cash Flow from Operating Activities | 3 | 5 | 1 | 7 | 11 | 8 | 16 | -3 | 20 | 8 | 47 |
| Cash Flow from Investing Activities | -3 | -5 | 0 | -4 | -10 | -8 | -14 | 5 | -18 | -3 | -40 |
| Cash Flow from Financing Activities | -0 | 1 | -2 | -1 | -1 | -1 | -2 | -2 | -2 | -4 | -6 |
| Net Cash Inflow / Outflow | 1 | 0 | -1 | 2 | 0 | -1 | 0 | -0 | -0 | 0 | 2 |
| Closing Cash & Cash Equivalent | 3 | -0 | -1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 3 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.82 | 0.95 | 0.7 | 2.01 | 3.33 | 5.61 | 7.29 | 4.27 | 9.18 | 11.74 | 17.32 |
| CEPS(Rs) | 1.01 | 1.22 | 1.05 | 2.35 | 3.7 | 5.99 | 8.2 | 4.51 | 9.54 | 12.45 | 17.68 |
| DPS(Rs) | 0.16 | 0.16 | 0.16 | 0.16 | 0.22 | 0.8 | 0.8 | 0.8 | 2 | 2.4 | 3.5 |
| Book NAV/Share(Rs) | 18.92 | 19.97 | 20.49 | 21.93 | 24.86 | 30.3 | 36.79 | 40.25 | 48.63 | 58.45 | 73.37 |
| Core EBITDA Margin(%) | 7.04 | 7.78 | 9.64 | 13.52 | 14.35 | 19.19 | 20.65 | 17.36 | 19.28 | 19.83 | 21.6 |
| EBIT Margin(%) | 7.3 | 9.96 | 10.16 | 13.93 | 15.37 | 21.3 | 23.24 | 21.12 | 24.63 | 22.88 | 23.53 |
| Pre Tax Margin(%) | 6.22 | 8.93 | 8.75 | 12.95 | 14.57 | 19.74 | 22.61 | 20.25 | 23.93 | 22.41 | 23.07 |
| PAT Margin (%) | 3.97 | 5.87 | 6.64 | 9.22 | 11.15 | 14.86 | 16.8 | 14.65 | 18.26 | 17.16 | 17.25 |
| Cash Profit Margin (%) | 5.16 | 7.58 | 9.94 | 10.93 | 12.51 | 15.92 | 17.66 | 15.94 | 19.08 | 17.88 | 17.75 |
| ROA(%) | 3.32 | 3.8 | 2.95 | 7.36 | 10.46 | 15.74 | 18.51 | 8.72 | 17.19 | 18.54 | 22.36 |
| ROE(%) | 4.17 | 4.88 | 3.45 | 9.34 | 14.12 | 20.26 | 23.26 | 10.76 | 20.55 | 22.32 | 26.08 |
| ROCE(%) | 7.18 | 7.84 | 5.02 | 13.51 | 19.1 | 28.85 | 32.12 | 15.51 | 27.72 | 29.77 | 35.58 |
| Receivable days | 54.21 | 64.4 | 36.6 | 52.75 | 33.84 | 16.06 | 22.62 | 58.71 | 40.34 | 53.62 | 37.24 |
| Inventory Days | 10.63 | 12.8 | 26.14 | 18.99 | 28.12 | 22.41 | 18.38 | 50.39 | 25.73 | 16.11 | 7.9 |
| Payable days | 52.33 | 73.52 | 30.47 | 40.97 | 35.66 | 29.15 | 36.76 | 78.14 | 44.3 | 50.33 | 32.18 |
| PER(x) | 29.39 | 47.57 | 41.56 | 15.09 | 8.1 | 10.35 | 17.19 | 25.89 | 33.21 | 54.51 | 46.55 |
| Price/Book(x) | 1.27 | 2.25 | 1.42 | 1.39 | 1.08 | 1.92 | 3.41 | 2.74 | 6.27 | 10.95 | 10.99 |
| Dividend Yield(%) | 0.66 | 0.36 | 0.55 | 0.53 | 0.82 | 1.38 | 0.64 | 0.72 | 0.66 | 0.38 | 0.43 |
| EV/Net Sales(x) | 1.16 | 2.73 | 2.77 | 1.35 | 0.85 | 1.18 | 2.32 | 3.5 | 5.87 | 9.02 | 7.96 |
| EV/Core EBITDA(x) | 13.63 | 23.37 | 20.58 | 8.64 | 5.08 | 5.26 | 9.61 | 15.63 | 24.1 | 37.73 | 33.13 |
| Net Sales Growth(%) | 38.07 | -17.59 | -34.84 | 104.29 | 37.82 | 27.01 | 23.48 | -39.04 | 76.69 | 39.26 | 43.05 |
| EBIT Growth(%) | 16.83 | 12.52 | -33.54 | 179.97 | 52.09 | 76 | 34.75 | -44.62 | 106.09 | 29.39 | 47.11 |
| PAT Growth(%) | 2.12 | 22.07 | -26.4 | 183.83 | 66.74 | 69.17 | 39.64 | -46.86 | 120.25 | 30.89 | 43.83 |
| EPS Growth(%) | 8.25 | 15.42 | -26.28 | 188.64 | 65.3 | 68.47 | 29.97 | -41.48 | 115.21 | 27.89 | 47.5 |
| Debt/Equity(x) | 0.07 | 0.04 | 0.06 | 0.03 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio(x) | 1.32 | 1.67 | 1.89 | 1.24 | 0.91 | 3.01 | 3.26 | 3.2 | 2.94 | 2.81 | 3.42 |
| Quick Ratio(x) | 1.25 | 1.34 | 1.46 | 1.03 | 0.46 | 2.78 | 2.84 | 2.54 | 2.6 | 2.49 | 3.33 |
| Interest Cover(x) | 6.79 | 9.62 | 7.19 | 14.19 | 19.16 | 13.65 | 36.84 | 24.26 | 35.07 | 47.83 | 50.66 |
| Total Debt/Mcap(x) | 0.05 | 0.02 | 0.05 | 0.02 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 71.72 | 71.72 | 71.72 | 71.72 | 71.72 | 71.72 | 71.72 | 71.72 | 71.72 | 71.72 |
| FII | 2.77 | 2.77 | 2.77 | 3.11 | 3.11 | 3.14 | 3.14 | 3.21 | 3.25 | 3.18 |
| DII | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.04 | 0.04 | 0.04 | 0.06 |
| Public | 25.51 | 25.51 | 25.51 | 25.16 | 25.16 | 25.13 | 25.09 | 25.02 | 24.99 | 25.03 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.3 | 0.3 | 0.3 | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 |
| FII | 0.01 | 0.01 | 0.01 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.11 | 0.11 | 0.11 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.42 | 0.42 | 0.42 | 2.12 | 2.12 | 2.12 | 2.12 | 2.12 | 2.12 | 2.12 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +43% | +52% | +21% | +18% |
| Operating Profit CAGR | +46% | +58% | +23% | +29% |
| PAT CAGR | +44% | +59% | +25% | +34% |
| Share Price CAGR | -24% | +58% | +47% | +38% |
| ROE Average | +26% | +23% | +21% | +14% |
| ROCE Average | +36% | +31% | +28% | +20% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 71.72 | 71.72 | 71.72 | 71.72 | 71.72 | 71.72 | 71.72 | 71.72 | 71.72 | 71.72 |
| FII | 2.77 | 2.77 | 2.77 | 3.11 | 3.11 | 3.14 | 3.14 | 3.21 | 3.25 | 3.18 |
| DII | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.04 | 0.04 | 0.04 | 0.06 |
| Public | 25.51 | 25.51 | 25.51 | 25.16 | 25.16 | 25.13 | 25.09 | 25.02 | 24.99 | 25.03 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.3 | 0.3 | 0.3 | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 |
| FII | 0.01 | 0.01 | 0.01 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.11 | 0.11 | 0.11 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.42 | 0.42 | 0.42 | 2.12 | 2.12 | 2.12 | 2.12 | 2.12 | 2.12 | 2.12 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.